Total planned funding: $165,266,136
Allocations
Countries/Regions
India | $165,266,136 |
Organizational Types
Unknown | $62,008,737 |
NGO | $47,859,099 |
Own Agency | $27,210,416 |
University | $16,282,112 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,200,000 |
Host Country Government Agency | $1,539,200 |
FBO | $1,100,000 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $69,332,343 |
Prevention | $40,317,643 |
Management and Operations | $20,179,149 |
Care | $19,780,605 |
Testing | $8,626,362 |
Treatment | $7,030,034 |
Budget Codes
OHSS: Health Systems Strengthening | $41,011,692 |
HVSI: Strategic Information | $23,791,900 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,910,184 |
HVMS: Management and Operations | $20,179,149 |
HBHC: Care: Adult Care and Support | $12,637,141 |
HVCT: Testing: HIV Testing and Counseling | $8,626,362 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,866,014 |
HTXS: Treatment: Adult Treatment | $6,624,763 |
HLAB: Laboratory Infrastructure | $4,528,751 |
HKID: Care: Orphans and Vulnerable Children | $4,515,239 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,555,455 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,461,723 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,076,918 |
PDCS: Care: Pediatric Care and Support | $551,307 |
PDTX: Treatment: Pediatric Treatment | $381,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$61,384,248
Countries/Regions
FHI 360:
$15,441,011
Countries/Regions
USG Aggregated Agencies:
$14,067,934
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions